Skip to main content

Find Clinical Trials

Home
Conditions
Myeloproliferative Neoplasm, Unclassifiable

Clinical trial condition

Myeloproliferative Neoplasm, Unclassifiable

Explore clinical trials studying Myeloproliferative Neoplasm, Unclassifiable. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm, Unclassifiable trial results

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

The Patient Cohort of the National Center for Precision Medicine in Leukemia

NCT05326919

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
Locations: Hôpital Avicenne Bobigny, France

Hopital Robert Debré Paris, France

Hôpital Saint Louis Paris, France

View Trial Details

Completed

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

NCT03566446

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +10 more
Locations: Herlev Hospital Herlev, Capital Region, Denmark

View Trial Details

Completed

Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador

NCT05825326

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Sociedad de Lucha Contra el Cáncer Guayaquil, Guayas, Ecuador

View Trial Details

Completed

MPN Podcast Pilot Study

NCT03907774

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Arizona State University Phoenix, Arizona, United States

View Trial Details

Active, Not Recruiting

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT03862157

Conditions: Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blood Coagulation Disorders, +43 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details